Table 2

Unique differentially methylated regions (DMRs) in naïve CD4+ T cells from patients with systemic lupus erythematosus with a history of (A) malar rash, (B) discoid rash or (C) neither cutaneous involvement

DMR geneDMR location# DM sites in DMRMean β caseMean β controlMean Δβ
(A) Malar rash
Hypo-DMR
 MIR886Chr5: 135416331–13541641260.330.44−0.12
 TACSTD2Chr1: 59043199–5904328040.510.70−0.19
 CTBP1, C4orf42Chr4: 1243980–124402440.640.76−0.12
 GFPT2Chr5: 179740743–17974112030.490.70−0.21
 C1orf86, LOC100128003Chr1: 2121039–212134920.380.51−0.13
 (Intergenic)Chr5: 1857306–185747720.540.68−0.14
 HLAH, HLAG, HLAJ, HCG4BChr6: 29895175–2989518720.250.35−0.10
 (Intergenic)Chr6: 156983263–15698331520.760.86−0.11
 SVOPLChr7: 138349158–13834944320.440.55−0.10
 TRIM69Chr15: 45028083–4502809820.560.66−0.10
 JPH3Chr16: 87682036–8768214220.670.79−0.12
 LOC728392Chr17: 5403337–540351620.530.63−0.10
 RUNX1Chr21: 36258423–3625849720.280.39−0.11
 RUNX1Chr21: 36259067–3625938320.290.41−0.11
Hyper-DMR
 LY6G5CChr6: 31650735–31651151130.690.540.15
 PM20D1Chr1: 205818956–20581949270.460.240.22
 HTR2AChr13: 47472138–4747234950.620.470.16
 (Intergenic)Chr3: 196705629–19670589840.510.380.13
 KCNA6Chr12: 4918848–491923040.330.100.23
 (Intergenic)Chr5: 154026371–15402644830.450.330.12
 MUC5BChr11: 1283875–128397030.230.100.13
 NINJ2Chr12: 739980–74033830.510.320.19
 CRIP2Chr14: 105945022–10594568530.620.490.13
 HOOK2Chr19: 12876846–1287700030.480.330.15
 THADAChr2: 43398171–4339833920.500.360.14
 HDAC4Chr2: 240142694–24014280620.670.540.13
 (Intergenic)Chr8: 43132451–4313250720.520.410.11
 (Intergenic)Chr11: 128694184–12869430320.550.440.11
 PLEKHG6Chr12: 6419570–641957520.400.290.11
 (Intergenic)Chr12: 11700321–1170048920.900.780.13
 SLC38A4Chr12: 47219737–4721979320.460.340.12
 (Intergenic)Chr13: 23309892–2330993020.660.530.13
 LIG4Chr13: 108867111–10886715420.500.380.12
 DEF8Chr16: 90016020–9001606120.730.570.16
 DHX58Chr17: 40259724–4025982820.330.210.12
 LASS4Chr19: 8273505–827369320.570.460.11
(B) Discoid rash
Hypo-DMR
 (Intergenic)Chr3: 195578040–19557828050.120.28−0.16
 TAP1Chr6: 32819911–3282021440.340.45−0.11
 RFPL2Chr22: 32599511–3259964840.400.52−0.12
 PRDM9Chr5: 23507573–2350761730.690.80−0.11
 RPH3ALChr17: 154420–15467130.380.49−0.11
 C1orf109Chr1: 38156462–3815665220.280.45−0.17
 SPINK9Chr5: 147699718–14769989220.480.59−0.11
 LY6G5CChr6: 31651020–3165102920.620.74−0.12
 PSMB8Chr6: 32810706–3281083320.500.63−0.13
 RHOJChr14: 63671356–6367173720.430.60−0.17
 BAIAP3Chr16: 1393584–139379720.560.68−0.12
 (Intergenic)Chr16: 53407722–5340780820.500.64−0.13
 (Intergenic)Chr17:6558365–655844020.500.67−0.16
 (Intergenic)Chr17: 37024020–3702404220.290.42−0.13
 TBC1D16Chr17: 77997833–7799799720.830.95−0.11
 SBNO2Chr19: 1155030–115518420.810.94−0.13
 C21orf81Chr21: 15352608–1535298320.350.48−0.13
Hyper-DMR
 RNF39Chr6: 30039142–30039524110.470.300.16
 (Intergenic)Chr7: 158789849–15879011530.550.420.14
 (Intergenic)Chr10: 43846281–4384653930.350.220.13
 MIPEPP3Chr13: 21900426–2190081030.600.480.12
 ZNF714Chr19: 21264896–2126542130.390.260.14
 C1orf65Chr1: 223566761–22356717320.390.290.10
 MYT1LChr2: 1801628–180204520.700.590.11
 TMEM175Chr4: 940644–94089320.630.520.11
 (Intergenic)Chr5: 74350132–7435021420.380.270.11
 GFPT2Chr5: 179740743–17974091420.600.470.13
 TRIM31Chr6: 30079265–3007928020.630.510.12
 (Intergenic)Chr6: 167559851–16755991320.590.450.14
 RADILChr7: 4848683–484881420.240.100.13
 (Intergenic)Chr8: 58055876–5805611320.500.380.12
 FGFR2Chr10: 123355268–12335557620.470.370.10
 RAD51BChr14: 69095570–6909567920.430.320.11
 (Intergenic)Chr15: 66947568–6694761720.370.260.12
 SMAD3Chr15: 67356838–6735694220.690.590.11
 SPIBChr19: 50931432–5093151520.320.200.12
 (Intergenic)Chr20: 61659980–6166025020.580.410.17
(C) No cutaneous involvement
Hypo-DMR
 TNXBChr6: 32063607–32064582150.340.49−0.15
 NFYA, LOC221442Chr6: 41068646–4106875250.760.96−0.21
 MUC4Chr3: 195489306–19548990940.630.77−0.13
(Intergenic)Chr7: 158789723–15879011540.430.59−0.16
 RAD51BChr14: 69095057–6909567940.310.44−0.12
(Intergenic)Chr1: 75590912–7559135330.340.46−0.12
(Intergenic)Chr6: 28447087–2844711530.300.42−0.12
 NINJ2Chr12: 739980–74033830.380.57−0.20
 KCNA6Chr12: 4919081–491923030.250.38−0.13
 LMTK3Chr19: 49000743–4900099830.650.76−0.12
 LMTK3Chr19: 49001890–4900247730.590.71−0.12
 MYT1LChr2: 1817263–181740920.580.70−0.11
(Intergenic)Chr4: 1550089–155019420.660.77−0.12
(Intergenic)Chr4: 6010075–601016420.460.56−0.11
 RGS14Chr5: 176797920–17679799920.460.57−0.12
 RNF39Chr6: 30039202–3003944220.320.45−0.13
 VARS2Chr6: 30882641–3088270820.440.57−0.13
 TAP2Chr6: 32805548–3280557020.550.67−0.12
 HOXA5Chr7: 27183375–2718369420.680.79−0.11
 PTPRN2Chr7: 158046166–15804622220.680.85−0.17
(Intergenic)Chr8: 1321333–132137520.400.53−0.12
(Intergenic)Chr10: 130726624–13072670120.680.80−0.12
 TRIM5Chr11: 5960015–596008120.690.80−0.11
 STAT3Chr17: 40489584–4048978520.270.40−0.13
 FLJ26850Chr19: 50554451–5055451020.060.22−0.16
 NLRP2Chr19: 55477653–5547781020.510.62−0.11
 HLCSChr21: 38362725–3836272720.570.71−0.14
 C21orf56Chr21: 47604166–4760429120.240.38−0.14
Hyper-DMR
 NAPRT1Chr8: 144659831–14466077250.370.230.14
 GSTM5Chr1: 110254662–11025470930.470.350.12
(Intergenic)Chr10: 1939618–193968330.670.510.16
 CD101Chr1: 117544206–11754441620.190.080.11
(Intergenic)Chr2: 731298–73151920.800.670.13
 (Intergenic)Chr2: 173539262–17353954220.500.400.11
 PRDM9Chr5: 23507594–2350761720.740.640.11
 FLOT1Chr6: 30706647–3070665420.680.570.11
 C11orf21, TSPAN32Chr11: 2322507–232251720.210.100.12
 (Intergenic)Chr12: 19557334–1955734320.250.130.11
 RARGChr12: 53612551–5361273420.530.410.12
 VSTM1Chr19: 54567123–5456727920.600.340.26
 SPATC1LChr21: 47581042–4758140520.610.500.11
 CERKChr22: 47135171–4713525820.320.130.19
 BCORChrX: 39956534–3995655820.310.190.12
 BCORChrX: 39958040–3995819620.340.200.14